Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

TO THE EDITOR:

  • 123456 Profile photo of Madelyn

    An analysis of 20 patients who relapsed post Axi-Cel CAR-T looked at patterns and mechanism of relapse. About 30% of patients relapse with Cd19 negative disease. Cd19 negative relapses were more common in patients with lower pretreatment tumor burden, and those with a longer time to relapse (9 vs 3 months).